Related Experiment Video
Updated: Nov 23, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
The year in cardiovascular medicine 2020: arrhythmias
Harry J G M Crijns1, Frits Prinzen2, Pier D Lambiase3
1Department of Cardiology and Cardiovascular Research Centre Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
Insights
Integrated nurse-led care and early rhythm control improve outcomes for atrial fibrillation (AF) patients. Subcutaneous implantable cardioverter-defibrillators (ICDs) are as effective as transvenous ICDs, with new diagnostic tools emerging.
Area of Science:
- Cardiology
- Electrophysiology
- Biomarker Discovery
Background:
- Advances in arrhythmia management in 2020 highlighted key areas for improving patient outcomes.
- Atrial fibrillation (AF) and Brugada syndrome represent significant challenges in cardiac care.
Purpose of the Study:
- To review and synthesize recent progress in the diagnosis and treatment of cardiac arrhythmias.
- To evaluate the efficacy of novel therapeutic strategies and diagnostic biomarkers.
Main Methods:
- Analysis of clinical trial data (RACE4, ALL-IN, PRAETORIAN) on AF management and implantable cardioverter-defibrillator (ICD) therapies.
- Review of mechanistic studies investigating biomarkers for Brugada syndrome and novel pacing techniques.
- Evaluation of ECG risk scores for predicting outcomes in ischemic heart disease.
Main Results:
- Integrated nurse-led care and early rhythm control significantly improve outcomes in AF patients.
- Subcutaneous ICDs demonstrated non-inferiority to transvenous ICDs.
- A novel biomarker profile for Brugada syndrome diagnosis was identified.
- Transseptal left ventricular (LV) pacing showed comparable efficacy to His bundle pacing.
- An ECG risk score improved risk prediction in ischemic heart disease patients.
Conclusions:
- Integrated care, early rhythm control, and subcutaneous ICDs represent significant advancements in AF management.
- Biomarker discovery and innovative pacing techniques offer new avenues for diagnosing and treating arrhythmias.
- Improved risk stratification tools can enhance the appropriate use of ICD therapy.
Abstract:
of the progress in arrhythmias in 2020. RACE4 and ALL-IN indicated that integrated nurse-led care improves outcomes in AF patients.3,4 The same was reported for early rhythm control therapy15 and cryoablation as initial AF treatment.25,26 Subcutaneous ICD was non-inferior to classical transvenous ICD therapy in PRAETORIAN.54 One mechanistic study showed that autoantibodies against misexpressed actin, keratin, and connexin-43 proteins create a blood-borne biomarker profile enhancing diagnosis of Brugada syndrome.50 Another mechanistic study indicated that transseptal LV pacing yields similar improvement in contractility as His bundle pacing whilst being more easy to execute.44 In PRE-DETERMINE a simple-to-use ECG risk score improved risk prediction in patients with ischemic heart disease possibly enhancing appropriate ICD therapy in high risk patients.58.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...

